Skip to main content
SpringerLink
Log in

Routine bone scanning in patients with T1 and T2 breast cancer: A waste of money

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Bone scans are often performed as routine staging procedures for patients with T1 and T2 breast cancers. Bone scanning in this patient population is evaluated with respect to cost and impact on clinical management.

Methods: Three hundred sixteen women with clinical T1 or T2 breast cancer who had bone scans were treated at Fox Chase Cancer Center from January of 1991 to December of 1992. We reviewed clinical and pathologic tumor stage, nodal status, laboratory studies, symptoms, bone scans (frequency, results, and cost), and resultant studies.

Results: Sixty-three women (20%) had bone scans that were interpreted as positive or suspicious for metastatic disease on initial presentation, resulting in 105 confirmatory studies, including 80 plain films, 10 computed tomography (CT) scans, 11 magnetic resonance imaging (MRI) scans, and four biopsies. Seven patients (2%) had skeletal metastases, six of whom had clinical stigmata of distant disease. A single patient (0.3%), with no signs or symptoms of distant disease, had bone metastases. The initial bone scans cost $224,676; additional tests cost another $53,122. The initial positive predictive value of bone scans in detecting metastatic disease was 11%. The “baseline” bone scans were followed by 130 “follow-up” scans over 2 years at a cost of $92,400. Seven patients developed metastatic disease, confirmed by 31 additional studies. Again, only one patient was asymptomatic. The availability of initial studies for comparison did not prevent thorough evaluation in women with worrisome follow-up bone scans.

Conclusions: Bone scans of 316 woman at initial presentation with T1 or T2 breast cancer identified one incurable patient whose management was changed. The cost was $277,798. Bone scans contribute little information to the management of asymptomatic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Miller AB. Causes of breast cancer and high-risk groups: incidence and demographics: radiation risk. In: Harris JB, Hellman S, Henderson IC, Kinne DW, eds.Breast disease. Philadelphia: JB Lippincott, 1991:119–26.

    Google Scholar 

  2. Baker RR, Holmes ER, Alderson PO, Khouri NF, Wagner HN. An evaluation of bone scans as screening procedures for occult metastases in primary breast cancer.Ann Surg 1977;186:363–8.

    CAS  PubMed  Google Scholar 

  3. Khansur T, Haick A, Patel B, Balducci L, Vance R, Thigpen T. Evaluation of bone scan as a screening work-up in primary and local-regional recurrence of breast cancer.Am J Clin Oncol 1987;10:167–70.

    CAS  PubMed  Google Scholar 

  4. Sklaroff RB, Sklaroff DM. Bone metastases from breast cancer at the time of radical mastectomy as detected by bone scan: eight year follow-up.Cancer 1976;38:107–11.

    CAS  PubMed  Google Scholar 

  5. Wickerham L, Fisher B, Cronin W, et al. The efficacy of bone scanning in the follow-up of patients with operable breast cancer.Breast Cancer Res Treat 1984;4:303–7.

    Article  CAS  PubMed  Google Scholar 

  6. Ciatto S, Pacini P, Bravetti P, Cataliotti L, Cardona G. Crescioli R, Pupi A. Staging breast cancer—screening for occult metastases.Tumori 1985;71:339–44.

    CAS  PubMed  Google Scholar 

  7. Feig SA. The role of new imaging modalities in staging and follow-up of breast cancer.Semin Oncol 1986;13:402–14.

    CAS  PubMed  Google Scholar 

  8. Bruce J, Carter DC, Fraser J. Patterns of recurrent disease in breast cancer.Lancet 1970;1:433–5.

    CAS  PubMed  Google Scholar 

  9. Lee YN. Bone scanning in patients with early breast carcinoma: should it be a routine staging procedure?Cancer 1981;47:486–95.

    CAS  PubMed  Google Scholar 

  10. O'Mara RE. Skeletal scanning in neoplastic disease.Cancer 1976;37:480–6.

    PubMed  Google Scholar 

  11. Forrest APM, Cant ELM, Roberts MM, Stewart HJ, Sumerling MD, Donaldson AA, Smith AF, et al. Is the investigation of patients with breast cancer for occult metastatic disease worthwhile?Br J Surg 1979;66:749–51.

    CAS  PubMed  Google Scholar 

  12. Campbell DJ, Banks AJ, Oates GD. The value of preliminary bone scanning in staging and assessing the prognosis of breast cancer.Br J Surg 1976;63:811–16.

    CAS  PubMed  Google Scholar 

  13. Monypenny IJ, Grieve RJ, Howell A, Morrison JM. The value of serial bone scanning in operable breast cancer.Br J Surg 1984;71:466–8.

    CAS  PubMed  Google Scholar 

  14. Davies J, Griffiths PA, Preston BJ, Morris AH, Elston CW, Blamey RW. Staging breast cancer: role of bone scanning.BMJ 1977;2:603–5.

    CAS  PubMed  Google Scholar 

  15. El-Domeiri AA, Shroff S. Role of preoperative bone scan in carcinoma of the breast.Surg Gynecol Obstet 1976;142:722–4.

    CAS  PubMed  Google Scholar 

  16. Derimanov SG. “For” or “against” bone scintigraphy of patients with breast cancer.Nucl Med Commun 1987;8:79–86.

    CAS  PubMed  Google Scholar 

  17. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ (eds).Handbook for staging of cancer. Philadelphia: WB Saunders, 1993:161–7.

    Google Scholar 

  18. Wilner D. Cancer metastases to bone. In: Wilner D, ed.Radiology of bone tumors and allied disorders. Philadelphia: WB Saunders, 1982:3612–53.

    Google Scholar 

  19. Citrin DL, Tormey DC, Carbone PP. Implications of the 99m Tc diphosphonate bone scan on treatment of primary breast cancer.Cancer Treat Rep 1977;61:1249–52.

    CAS  PubMed  Google Scholar 

  20. Rogers LF. Bone tumors and related conditions. In: Juhl JH, Crummy AB, eds.Essentials of radiologic imaging. Philadelphia: JB Lippincott, 1987:131–71.

    Google Scholar 

  21. Hoffman HC, Marty R. Bone scanning: its value in the preoperative evaluation of patients with suspicious breast masses.Am J Surg 1972;124:194–9.

    Article  CAS  PubMed  Google Scholar 

  22. Galasko CS. The significance of occult skeletal metastases, detected by skeletal scintigraphy, in patients with otherwise apparent “early” mammary carcinoma.Br J Surg 1975;62:694–6.

    CAS  PubMed  Google Scholar 

  23. Roberts JG, Gravelle IH, Baum M. Evaluation of radiographic and isotope scintigraphy in breast cancer.Lancet 1976;1:237–9.

    CAS  PubMed  Google Scholar 

  24. Scanlon EF, Oviedo MA, Cunningham MP, Caprini JA, Khandekar JD, Cohen E, Robinson B, et al. Preoperative and follow-up procedures on patients with breast cancer.Cancer 1980;46:977–9.

    CAS  PubMed  Google Scholar 

  25. Wilson GS, Rich MA, Brennan MJ. Evaluation of bone scan in preoperative clinical staging of breast cancer.Arch Surg 1980;115:415–19.

    CAS  PubMed  Google Scholar 

  26. Citrin DL, Furnival CM, Bessent RG, Greig WR, Bell G, Blumgart LH. Radioactive technetium phosphate bone scanning in preoperative assessment and follow-up study of patients with primary carcinoma of the breast.Surg Gynecol Obstet 1976;143:360–4.

    CAS  PubMed  Google Scholar 

  27. Piffer S, Armichetti M, Valentini A. Skeletal scintigraphy and physical examination in the staging of early breast cancer.Acta Oncol 1988;27:21–4.

    CAS  PubMed  Google Scholar 

  28. Furnival CM, Blumgart LH, Citrin DL, McKillop JH, Fogelman I, Greig WR. Serial scintiscanning in breast cancer: the indications and prognostic value.Clin Oncol 1980;6:25–32.

    CAS  PubMed  Google Scholar 

  29. Schutte HE. The influence of bone pain on the results of bone scans.Cancer 1979;44:2039–43.

    CAS  PubMed  Google Scholar 

  30. Gerber FH, Goodreau JJ, Kirchner PT, Fouty WJ. Efficacy of preoperative and postoperative bone scanning in the management of breast carcinoma.N Engl J Med 1977;297:300–3.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Director of Surgical Research, Fox Chase Cancer Center, 7701 Burholme Avenue, 19111, Philadelphia, PA, USA

    Karen A. Yeh MD, Lucio Fortunato MD, John A. Ridge MD, PhD, John P. Hoffman MD, Burton L. Eisenberg MD &  Elin R. Sigurdson MD, PhD

Authors
  1. Karen A. Yeh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lucio Fortunato MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John A. Ridge MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John P. Hoffman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Burton L. Eisenberg MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elin R. Sigurdson MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yeh, K.A., Fortunato, L., Ridge, J.A. et al. Routine bone scanning in patients with T1 and T2 breast cancer: A waste of money. Annals of Surgical Oncology 2, 319–324 (1995). https://doi.org/10.1007/BF02307064

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02307064

Key Words

Search

Navigation